Harbour Antibodies BV Raises €2.5M ($3.3M) to Accelerate the Development of ... Fort Mills Times Harbour Antibodies BV, the creator of transgenic mice to aid in the discovery of new human antibody-based therapies, has raised €2.5M ($3.3M) to continue R&D and commercialize its technologies. The round was led by Atlas Venture. With the funding ... Harbour Antibodies Licenses H2L2 Mice to Pfizer Atlas leads €2.5m round for Harbour Antibodies Pfizer licenses antibody tech from Atlas-backed startup Harbour |
